References
- Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1–15.
- Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002;186:1621–30.
- Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 2009;44:239–48.
- Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori cagA protein. Nat Rev Cancer 2004;4:688–94.
- Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Biological activity of the Helicobacter pylori virulence factor cagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002;99:14428–33.
- Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science 2002;295:683–6.
- Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999;44:336–41.
- Dixon MF, Genta RM, Yardley JH. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston. Am J Surg Pathol 1996;20:1161–81.
- Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090–6.
- Ueda H, Ito M, Eguchi H, Tanaka S, Yoshihara M, Haruma K, Development of a novel method to detect Helicobacter pylori cagA genotype from paraffin-embedded materials: comparison between patients with duodenal ulcer and gastric cancer in young Japanese. Digestion 2006;73:47–53.
- Xie XF, Ito M, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori-associated gastritis is related to babA2 expression without heterogeneity of the 3′ region of the cagA genotype in gastric biopsy specimens. Pathobiology 2007;74:309–16.
- Infection with Helicobacter pylori. In IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 61. Schitosomes, liver flukes and Helicobacter pylori. Lyon. France: International Agency for Research on Cancer; 1994. pp 177–241.
- Forman D, Webb P, Parsonnet J. H. pylori and gastric cancer. Lancet 1994;343:243–4.
- Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, Association between diversity in the Src homology 2 domain–containing tyrosine phosphatase binding site of Helicobacter pylori cagA protein and gastric atrophy and cancer. J Infect Dis 2004;189:820–7.
- Muller LB, Fagundes RB, Moraaes CC. Prevalence of Helicobacter pylori infection and gastric cancer precursor lesion in patients with dyspepsia. Arq Gastroenterol 2007;44:93–8.
- Gatti LL, Labio R. Cag A positive Helicobacter pylori in Brazilian children related to chronic gastritis. Braz J Infect Dis 2006;10:254–8.
- Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T, Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002;93:1083–9.
- Uchida T, Kanada R, Tsukamoto Y, Hijiya N, Matsuura K, Yano S, Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci 2007;98:521–8.
- Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:350–2.
- Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009;44:365–71.
- Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol 2010;45:1–8.